Prevalence of CD8 + cytotoxic lymphocytes in human neoplasms
ConclusionThese data support the concept that among most tumor types at least some individual cancers may benefit from treatment with immune checkpoint inhibitors.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Angiosarcoma | Cancer | Cancer & Oncology | Carcinoma | Embryonal Carcinoma | Kidney Cancer | Lung Cancer | Lymphoma | Melanoma | Merkel Cell Carcinoma | Renal Cell Carcinoma | Skin Cancer | Squamous Cell Carcinoma | Thyroid | Thyroid Cancer